Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy
Not Applicable
Completed
- Conditions
- Proliferative Diabetic Retinopathy - High Risk
- Registration Number
- NCT06653361
- Lead Sponsor
- Hayatabad Medical Complex
- Brief Summary
Proliferative diabetic retinopathy is a vision-threatening disease that can lead to irreversible visual loss. The treatment options for proliferative diabetic retinopathy are anti-VEGF injection and retinal photocoagulation. The study aims to compare ultra-widefield fluorescein angiography-based targeted retinal photocoagulation and panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- proliferative diabetic retinopathy (PDR) with neovascularization on the disc or elsewhere in the retina
Exclusion Criteria
- Participants with a history of previous history of:
- retinal photocoagulation
- vitreoretinal surgery
- tractional retinal detachment
- epiretinal membrane
- vitreomacular traction
- glaucoma
- uveitis
- media opacities like cataract, corneal opacity, vitreous hemorrhage
- anti-VEGF injections in last 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method CMT 2 months Central Macular Thickness
MD 2 months Mean Deviation
VFI 2 months Visual Filed Index
BCVA 2 months Best Corrected Visual Acuity
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Khyber Teaching Hospital Peshawar
🇵🇰Peshawar, KP, Pakistan